Cleveland BioLabs Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Cleveland BioLabs Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Cleveland BioLabs, with an average price target of $0.00. This potential loss of -,100 percent from the previous closing price in August, 2021 is calculated on a high forecast of $0.00 and a low estimate of $0.00. Even if you are not interested in CBLI stock, it is still crucial to be aware of its competitors.
N/A
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$734.37 | Buy/Sell | $636.99 | 10.71% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$161.23 | Buy/Sell | $174.55 | 5.44% |
MRK Stock Forecast | Merck | Outperform |
2
|
$122.77 | Buy/Sell | $130.51 | 9.96% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.37 | Buy/Sell | $32.87 | 10.82% |
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$54.36 | Buy/Sell | $58.15 | 1.18% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$414.47 | Buy/Sell | $457.59 | 8.57% |
REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$964.44 | Buy/Sell | $961.26 | 8.87% |
ZTS Stock Forecast | Zoetis | Outperform |
18
|
$183.49 | Buy/Sell | $220.47 | 20.72% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$43.48 | Buy/Sell | $44.86 | 3.50% |
ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$149.10 | Buy/Sell | $245.24 | 44.20% |
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.97 | Buy/Sell | $11.73 | 0.25% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$249.51 | Buy/Sell | $284.08 | 19.63% |
CTLT Stock Forecast | Catalent | Hold |
15
|
$56.81 | Buy/Sell | $49.29 | 11.78% |
CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$64.39 | Buy/Sell | $87.92 | 45.99% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$43.26 | Buy/Sell | $55.60 | 41.01% |
MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$260.15 | Buy/Sell | $315.92 | 29.16% |
BCPC Stock Forecast | Balchem | Outperform |
18
|
$156.04 | Buy/Sell | $145.00 | 4.46% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NEOG Stock Forecast | Neogen | Outperform |
16
|
$16.19 | Buy/Sell | $37.00 | 17.36% |
PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.59 | Buy/Sell | $44.75 | 27.49% |
AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$43.81 | Buy/Sell | $69.00 | 41.52% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$16.37 | Buy/Sell | $29.44 | 107.70% |
CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$23.75 | Buy/Sell | $35.67 | 60.00% |
INDV Stock Forecast | Indivior PLC | Buy |
14
|
£16.50 | Buy/Sell | £28.89 | 92.00% |